Kumar, A. 2016. EFAVIRENZ, A WELL KNOWN ANTIVIRAL DRUG, MIGHT BE A NEW OPTION IN THE TREATMENT OF CANCER. International Journal of Pharmacy and Pharmaceutical Sciences. 8, 7 (Jul. 2016), 6–7.